Navigation Links
Rudd Report Gives AMDL, Inc. a Strong Buy Recommendation in Year-End Financial Research Report
Date:1/6/2009

TUSTIN, Calif., Jan. 6 /PRNewswire-FirstCall/ -- AMDL, Inc. (Amex: ADL), a vertically integrated pharmaceutical company with operations in China and the US, announced today industry analyst Lauren Rudd has issued a strong buy recommendation for AMDL in his year-end financial research report on the Company.

The report projects a 12-month target price of $5.00 for AMDL and highlights the Company's:

    -- Consistent, positive historical financial performance over the past
       four years
    -- Most recent operational changes and business updates, including an
       updated overview of AMDL's China-based subsidiary Jade Pharmaceuticals,
       Inc.
    -- FY2009 product pipeline
    -- FY2009 plans for the AMDL ELISA DR-70(R) (FDP) cancer monitoring test;
       best-selling Human Placenta Extract (HPE) anti-aging product line; and
       MYHPV Chip(R) diagnostic test kit which detects approximately 28
       different strains of the Human Papilloma Virus.

The research report also provides a thorough peer group comparison with valuation analyses, views and opinions on AMDL's projected financial performance for the 2009 fiscal year, and historical financials.

According to Mr. Rudd, "AMDL has taken major initiatives to build its strengths while reorganizing top management and still producing respectable financials which has resulted in AMDL being one of the most under priced stocks we have seen in a long time."

A full copy of the report is available for downloading online at http://www.ruddreport.com or by contacting Ms. Kristine Szarkowitz, AMDL's Director Investor Relations, at kszarkowitz@amdl.com.

About AMDL:

Headquartered in Tustin, CA with operations in Shenzhen, Jiangxi, and Jilin, China, AMDL, Inc., along with its subsidiary Jade Pharmaceutical Inc. (JPI), is a vertically integrated pharmaceutical company devoted to the research, development, manufacturing, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products. The company employs over 490 people in the U.S. and China.

Forward Looking Statements:

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this document include certain predictions and projections that may be considered forward-looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company's operations, markets, services, products, and prices. With respect to AMDL Inc., except for the historical information contained herein, the matters discussed in this document are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements.

     AMDL Contact:
     Kristine Szarkowitz
     Director-Investor Relations
     kszarkowitz@amdl.com
     (Tel :) 206.310.5323

'/>"/>
SOURCE AMDL, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Consumer Reports: Big Promises of Some Infomercial Exercise Machines Fall Flat; Plus, Set Up a Home Gym for Under $100
2. Cardium Reports on Exchange Listing With NYSE Alternext US
3. CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte Closes
4. Joint Commission Reports Positive Survey Results for CHA
5. Fisher Vista, LLC Reports Seventh Consecutive Year of Revenue Growth and Profitability
6. Fisher Vista, LLC Reports Seventh Consecutive Year of Revenue Growth and Profitability
7. Risks and Benefits of Egg Donation Reported
8. LegalView Updates its Baxter Heparin Information Portal with Conflicting News Reports on the Possible Dangers
9. Despite Sagging Economy, Viamedic Reports Solid Online Sales for Erectile Dysfunction Drugs
10. 5,000 Medical Leaders Report Latest Advancements in Biomedical Technologies; Breakthroughs by 2015 Predicted for Alzheimer's, Heart Disease, Cancer, and Diabetes
11. Published reports inaccurate concerning alcohol consumption during pregnancy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... ... countries to hospitals in the United States, it’s a threat that is constantly ... obstacles facing infection prevention and offers strategies for the healthcare community to help ...
(Date:3/24/2017)... ... March 24, 2017 , ... The Radiology Business Management Association (RBMA) ... awards, now in their 12th year, are among the most prestigious in radiology marketing ... the awards were retooled to recognize achievements in both large budget (over $5,000) and ...
(Date:3/24/2017)... , ... March 24, 2017 , ... Texas Physical ... can be found at 9618 Huebner Road. The clinic is the group’s 7th location ... Director, and Dr. Ali Higgins, PT, will provide care from the clinic, which opened ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... planning, and related services to families and business owners across eastern Michigan, is ... feeding regional families struggling with financial difficulties. , The Oxford/Orion FISH Food Pantry ...
(Date:3/24/2017)... San Diego, Calif. (PRWEB) , ... March 24, ... ... (ADI) has raised over $100,000 for its innovative EcoQube Frame vertical micro-veggies garden ... demonstrates the instant demand for the product – with nearly 2,000 consumers (and ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... GENEVA , March 24, 2017 /PRNewswire/ ... Day revitalizes efforts to develop sutezolid as effective response ... Tuberculosis Day, TB Alliance and the Medicines Patent Pool ... of sutezolid, an antibiotic drug candidate which demonstrated encouraging ... development of sutezolid in combination with other TB drugs ...
(Date:3/23/2017)... 2017 The key factors driving the ... population, accelerating economic growth and increasing healthcare expenditure. Some of ... life expectancy of ESRD patients, rising demand for home PD ... expansion of the market is hindered by high treatment costs ... ...
(Date:3/23/2017)... INDIANAPOLIS , March 23, 2017  Eli ... the William Sansum Diabetes Center have established a research ... by diabetes through enhanced research, education and care. ... disease bears a disproportionate weight on Latino families in ... David Kerr , M.D., FRCPE, director of Innovation and ...
Breaking Medicine Technology: